Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: J Surg Oncol. 2021 Jul 26;124(7):1106–1114. doi: 10.1002/jso.26619

Table 4:

Cox Proportional Hazards Regression for Time to Cancer Recurrence in Propensity Score Matched Cohort (N=528)

Characteristic HR (95%CI) P value
Bowel Prep
 No 1.0 REF
 Yes 0.57 (0.37–0.89) <0.05
Age 1.00 (0.98–1.02) 0.906
Gender
 Male 1.0 REF
 Female 1.32 (0.85–2.03) 0.212
Race
 White 1.0 REF
 Black 0.64 (0.38–1.07) 0.089
 Asian 0.15 (0.02–1.16) 0.070
 Other 2.16 (0.70–6.66) 0.178
BMI
 < 18.5 1.19 (0.49–2.89) 0.697
 18.5 – 24.9 1.0 REF
 25 – 29.9 0.49 (0.28–0.87) <0.05
 >30 0.85 (0.50–1.44) 0.540
 Unknown 0.61 (0.14–2.66) 0.511
Stage
 Stage 1 1.0 REF
 Stage 2 2.14 (1.01–2.89) <0.05
 Stage 3 3.01 (1.43–6.28) <0.05
 Stage 4 1.09 (0.43–2.80) 0.854
Site
 Colon 1.78 (1.06–2.99) <0.05
 Rectum 1.0 REF
Emergent Surgery
 No 1.0 REF
 Yes 5.34 (1.11–25.6) <0.05
Anastomotic Leak
 No 1.0 REF
 Yes 1.05 (0.40–2.79) 0.915
SSI
 No 1.0 REF
 Yes 0.46 (0.20–1.03) 0.060
Radiation
 No 1.0 REF
 Yes 2.01 (1.24–3.26) <0.01
Chemotherapy
 No 1.0 REF
 Yes 1.78 (1.11–2.85) <0.05
Blood Transfusion
 No 1.0 REF
 Yes 0.74 (0.34–1.59) 0.433
Years of Follow Up
 1 year 1.0 REF
 2 years 1.06 (0.33–3.42) 0.917
 3 years 0.92 (0.29–2.90) 0.890
 4 years 0.61 (0.18–2.07) 0.430
 5 years 0.62 (0.17–2.24) 0.463
6 years 0.22 (0.05–0.95) <0.05

BMI = body mass index

SSI = surgical site infection